Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/06/2010EP1751093B1 Substituted cyclohexylacetic acid derivatives
10/06/2010EP1725555B1 Pyrrolopyridine-2-carboxylic acid hydrazides as inhibitors of glycogen phosphorylase
10/06/2010EP1723144B1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/06/2010EP1689726B1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
10/06/2010EP1637132B1 External preparation for athlete´s foot treatment
10/06/2010EP1633752B1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
10/06/2010EP1565158B1 Oxazolidinones for pharmaceutical use in skin pathologies, autoimmune disorders, photoimmunosuppression and graft rejection
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use
10/06/2010EP1451193B1 Podophyllotoxins as antiproliferative agents
10/06/2010EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds
10/06/2010EP1352077B1 Materials and methods relating to protein aggregation in neurodegenerative disease
10/06/2010EP1309569B1 N-aryl-{4-[7-(alkoxy)quinazolin-4-yl]piperazinyl}carboxamide derivatives as PDGFRs inhibitors
10/06/2010EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010CN1985813B Metronidazole ethanolamine spray as blood flukedisease preventing and treating medicine for farm cattle and its preparing method
10/06/2010CN1976696B Pharmaceutical composition for prevention or treatment of lipid metabolism disorder
10/06/2010CN1969843B Application of allantoin in preparation of medicament for treating gallbladder disease and gastrointestinal convulsion
10/06/2010CN1942186B Pyrrolidine compounds
10/06/2010CN1942172B Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
10/06/2010CN1927188B Voltage endurance vitamin E microcapsule and its preparing process
10/06/2010CN1914212B Polymorphic forms of a GABAA agonist
10/06/2010CN1864667B A stable lyophilized preparation of rocuronium bromide and preparation method thereof
10/06/2010CN1863524B Neutralizing agent for cavitating toxin
10/06/2010CN1857220B Slow released antituberculotic preparation
10/06/2010CN1853626B Zinc sulfate freeze-dried preparation for injection
10/06/2010CN1829512B Medicinal composition containing triazole compound
10/06/2010CN1784215B Melanogenesis promoter and melanogenesis promoter composition
10/06/2010CN1777417B Use of a pparalpha agonist and metformin for decreasing the serum triglycerides
10/06/2010CN1771931B Use of diterpene compound in preparing medicines with synergistic effect to chemical therapy medicines
10/06/2010CN1769286B Compound and pharmaceutical composition for treating nasal oversecreation and chronic obstructive pulmonary disease
10/06/2010CN1690047B 9-substituted minocycline compounds
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1665501B Novel compounds as opioid receptor modulators
10/06/2010CN1663559B Skin normalizing agents
10/06/2010CN1654480B Soluble highly branched glucose polymers
10/06/2010CN1635996B Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-D-glucopyranoside
10/06/2010CN1626076B Andrographolide drop pills and preparation method
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN1520300B Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/06/2010CN1514726B Pharmaceutical compositions
10/06/2010CN101855349A West nile virus vaccine, and method for production thereof
10/06/2010CN101855346A PKIB and NAALADL2 for target genes of prostate cancer therapy and diagnosis
10/06/2010CN101855234A Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine
10/06/2010CN101855229A Spirocyclic aminoquinolones as GSK-3 inhibitors
10/06/2010CN101855228A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
10/06/2010CN101855227A Heterocyclic derivatives
10/06/2010CN101855226A Increasing the in vivo biological activity of biologically active compounds
10/06/2010CN101855224A Equilibrative nucleoside transporter ENT1 inhibitors
10/06/2010CN101855222A Imidazol (1,2-A)pyridines and related compounds with activity at cannabinoid CB2 receptors
10/06/2010CN101855221A Pyridazinone derivatives as PARP inhibitors
10/06/2010CN101855220A Drug active in neuropathic pain
10/06/2010CN101855218A Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
10/06/2010CN101855214A Benzimidazole derivatives and their use as FXR agonists
10/06/2010CN101855213A Therapeutic compounds
10/06/2010CN101855212A Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain
10/06/2010CN101855211A Phenylpyrazole derivatives
10/06/2010CN101855210A Amides useful as inhibitors of voltage-gated sodium channels
10/06/2010CN101855209A Alkylsulfone derivative
10/06/2010CN101855208A 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/06/2010CN101855200A New polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
10/06/2010CN101855199A Tricyclic amide compound
10/06/2010CN101854979A C-19 steroids for therapeutic uses
10/06/2010CN101854944A Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts
10/06/2010CN101854939A 眼科用组合物 Ophthalmic composition
10/06/2010CN101854938A Compositions and methods for the identification of inhibitors of retroviral infection
10/06/2010CN101854937A Novel stat3 pathway inhibitors and cancer stem cell inhibitors
10/06/2010CN101854936A Dose forms comprising VX- 950 and their dosage regimen
10/06/2010CN101854935A Metabotropic glutamate receptor modulators for the treatment op parkinson's disease
10/06/2010CN101854933A Compounds that modulate intracellular calcium
10/06/2010CN101854932A Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists
10/06/2010CN101854930A A novel group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors
10/06/2010CN101854929A Novel preparation
10/06/2010CN101854928A Avenanthramide-containing compositions
10/06/2010CN101854927A Use of anti-bacterial compounds having an anaesthetic effect
10/06/2010CN101854926A Endoparasiticidal topical compositions
10/06/2010CN101854925A Use of a monoterpene to increase tissue repair
10/06/2010CN101854924A Methods and compositions for measuring WNT activation and for treating WNT-related cancers
10/06/2010CN101854922A Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
10/06/2010CN101854921A Pharmaceutical formulations for the oral administration of ppi
10/06/2010CN101854919A Compositions for the treatment of neoplastic diseases
10/06/2010CN101854915A Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same
10/06/2010CN101854913A Pharmaceutical compositions
10/06/2010CN101854911A Composition for external use
10/06/2010CN101854909A Skin-whitening agent containing platycodin D
10/06/2010CN101854908A C-19 steroids for cosmetic and further uses
10/06/2010CN101854907A Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid
10/06/2010CN101854905A Composition for external application to skin
10/06/2010CN101854903A Resveratrol ferulate compounds, compositions containing the compounds, and methods of using the same
10/06/2010CN101854815A Powder composition
10/06/2010CN101852782A Method for measuring impurity content of faropenem polymers in faropenem sodium raw materials and preparations
10/06/2010CN101852780A Novel method for detecting piperacillin sodium and sulbactam sodium for compound injection
10/06/2010CN101851621A Microbial molecular marker and construction and application thereof
10/06/2010CN101851304A Production process for manufacturing solid-phase povidone iodine
10/06/2010CN101851298A Sulfated galactan and preparation method thereof
10/06/2010CN101851278A B cell activating factor antagonist as well as preparation method and application thereof
10/06/2010CN101851273A Glaucocalyxin A derivative, preparation method and application thereof
10/06/2010CN101851272A Glaucocalyxin B, derivative, preparation method and application thereof
10/06/2010CN101851271A Glaucocalyxin D derivative, preparation method and application thereof
10/06/2010CN101851266A Novel cycloartane triterpenoidsaponins and preparation method and application thereof
1 ... 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 ... 7860